سعر Omnipaque 300 مجم iodine/مل 2026

Omnipaque 300 (iohexol, 300 mg iodine/mL) 20 mL, a non-ionic iodinated radiographic contrast medium by GE HealthCare (Amersham Health, Ireland), distributed in Egypt by New Technology.

• Radiographic contrast agent for intra-arterial and intravenous imaging procedures (e.g. angiography, excretory urography, contrast-enhanced CT) in adults and pediatric patients, per the procedure-specific concentrations of the US label.Population: Adults and pediatric patients (procedure-dependent)DailyMed (U.S. National Library of Medicine)
• Intrathecal use (myelography, CT myelography and CT cisternography in adults and children aged 2 weeks and older) is approved in the US only for specified concentrations and presentations; 300 mg iodine/mL is among the intrathecal concentrations, subject to the label dosing table.Population: Adults and pediatric patients 2 weeks and olderDailyMed (U.S. National Library of Medicine)

• Most common (1% or more) after intrathecal use in adults: headache, pain (backache, neckache, stiffness, neuralgia), nausea, vomiting and dizziness.International label, same product · DailyMed (U.S. National Library of Medicine)
• Most common (1% or more) after intra-arterial or intravenous use: pain, vision abnormalities (including blurred vision and photomas), headache and taste perversion, among others listed in the label.International label, same product · DailyMed (U.S. National Library of Medicine)

• Hysterosalpingography is contraindicated during pregnancy or suspected pregnancy, menstruation or imminent menstruation, within 6 months after termination of pregnancy, within 30 days after conization or curettage, with genital tract infection, or with known or suspected reproductive tract neoplasia.International label, same product · DailyMed (U.S. National Library of Medicine)

• Boxed warning (US): intrathecal administration of OMNIPAQUE 140 or 350 mg iodine/mL, even if inadvertent, may cause death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, rhabdomyolysis, hyperthermia and brain edema; use only concentrations and presentations recommended for intrathecal procedures.International label, same product · DailyMed (U.S. National Library of Medicine)
• Life-threatening or fatal hypersensitivity reactions including anaphylaxis can occur; have emergency equipment and trained personnel available.International label, same product · DailyMed (U.S. National Library of Medicine)
• Acute kidney injury including renal failure can occur; minimize the dose and maintain adequate hydration.International label, same product · DailyMed (U.S. National Library of Medicine)

• MetforminIodinated contrast may increase the risk of metformin-associated lactic acidosis; stop metformin at or before the procedure in patients with eGFR 30-60 mL/min/1.73 m2, hepatic impairment, alcoholism, heart failure or intra-arterial contrast; re-evaluate eGFR after 48 hours before restarting.DailyMed (U.S. National Library of Medicine)
• Radioactive iodine (I-131, I-123)Iohexol may decrease thyroid uptake of radioactive iodine; avoid thyroid therapy or testing for up to 6 weeks afterwards.DailyMed (U.S. National Library of Medicine)
• Protein-bound iodine test (laboratory)Temporarily increases protein-bound iodine in blood; do not perform the test for at least 16 days after administration.DailyMed (U.S. National Library of Medicine)

• No human data to inform drug-associated risk; iohexol crosses the placenta in small amounts; no developmental toxicity in rats and rabbits at the doses studied. Hysterosalpingography is contraindicated in pregnancy.International label, same product · DailyMed (U.S. National Library of Medicine)
• Iodinated contrast is excreted unchanged in very low amounts in milk and poorly absorbed by the infant (about 0.7% of the maternal IV dose); interruption of breastfeeding is not necessary, though a temporary pause can minimize exposure.International label, same product · DailyMed (U.S. National Library of Medicine)

• Iohexol: Organically bound iodine attenuates X-rays, opacifying the vessels, spaces or structures it fills.